Vertical Longevity Pharmaceuticals, Inc.

New Filing
CIK: 0002087846·Biotechnology·DELAWARE·Filed: Sep 25, 2026
Total Offering

$110,000

Amount Sold

$110,000

Investors

5

First Sale

Nov 4, 2025

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
David Philip Scieszka
Related Person

Company

Vertical Longevity Pharmaceuticals, Inc.

17 RINCON

IRVINE, CA, 92620

7608558072

SEC Filing

0002087846-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free